DownloadHi-Res Photo

Michael Bloch, MD, MS

Associate Professor in the Child Study Center; Director and Co-Founder of the Pediatric Depression Clinic, Child Study Center; Co-Director of the T32 Postdoctoral Research Fellowship in Childhood Neuropsychiatric Disorders, Child Study Center; Associate Program Director, Albert J. Solnit Integrated Training Program, Child Study Center; Co-Director of the Tic and OCD Program, Child Study Center

Research & Publications
Biography
News
Locations

Research Summary

Michael H. Bloch's research interests focus on studying Tourette syndrome (TS), Obsessive-compulsive disorder (OCD), Trichotillomania (TTM) across the lifespan and depression and anxiety in pediatric patients. His research focuses on developing better treatments for children and adults with these conditions and improving the evidence to personalize treatment (e.g. determine which patients respond best to which treatments)

Specialized Terms: Tourette syndrome; Obsessive-compulsive disorder; Trichotillomania, Psychopharmacology, Depression

Extensive Research Description

Michael H. Bloch, M.D., M.S. graduated from Yale School of Medicine and completed his child and adult psychiatry training at Yale. He is currently an Associate Professor at the Yale Child Study Center. His research focuses on evidence-based medicine and developing improved treatments for individuals with mental illness across the lifespan using clinical trials and meta-analysis. His clinical and research interests concentrate on depression, anxiety, Tourette syndrome, ADHD, trichotillomania and OCD across the lifespan. He has published over 125 peer-reviewed manuscripts and was co-editor of the fifth edition of the Lewis Textbook of Child and Adolescent Psychiatry. He serves on the editorial boards of the Journal of the American Academy of Child Psychiatry, Journal of Child Psychology and Psychiatry, Journal of Child and Adolescent Psychopharmacology and Depression and Anxiety.

Coauthors

Research Interests

Anxiety; Attention Deficit Disorder with Hyperactivity; Child Psychiatry; Depression; Tourette Syndrome; Obsessive-Compulsive Disorder; Psychopharmacology; Trichotillomania; Meta-Analysis

Selected Publications

Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysisFarhat L, Behling E, Landeros-Weisenberger A, Levine J, Macul Ferreira de Barros P, Wang Z, Bloch M. Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis. The Lancet Child & Adolescent Health 2022, 7: 112-126. PMID: 36528030, DOI: 10.1016/s2352-4642(22)00316-9.
The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysisFarhat LC, Flores JM, Behling E, Avila-Quintero VJ, Lombroso A, Cortese S, Polanczyk GV, Bloch MH. The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis. Molecular Psychiatry 2022, 27: 1562-1572. PMID: 35027679, DOI: 10.1038/s41380-021-01391-9.
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled TrialDwyer JB, Landeros-Weisenberger A, Johnson JA, Londono Tobon A, Flores JM, Nasir M, Couloures K, Sanacora G, Bloch MH. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial. American Journal Of Psychiatry 2021, 178: 352-362. PMID: 33653121, DOI: 10.1176/appi.ajp.2020.20010018.
Pharmacological and behavioral treatment for trichotillomania: An updated systematic review with meta‐analysisFarhat LC, Olfson E, Nasir M, Levine JLS, Li F, Miguel EC, Bloch MH. Pharmacological and behavioral treatment for trichotillomania: An updated systematic review with meta‐analysis. Depression And Anxiety 2020, 37: 715-727. PMID: 32390221, DOI: 10.1002/da.23028.
Annual Research Review: Defining and treating pediatric treatment‐resistant depressionDwyer JB, Stringaris A, Brent DA, Bloch MH. Annual Research Review: Defining and treating pediatric treatment‐resistant depression. Journal Of Child Psychology And Psychiatry 2020, 61: 312-332. PMID: 32020643, PMCID: PMC8314167, DOI: 10.1111/jcpp.13202.
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-AnalysisWilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, Sos P, Wang G, Zarate CA, Sanacora G. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. American Journal Of Psychiatry 2017, 175: 150-158. PMID: 28969441, PMCID: PMC5794524, DOI: 10.1176/appi.ajp.2017.17040472.
Meta-Analysis of the Symptom Structure of Obsessive-Compulsive DisorderBloch M, Landeros-Weisenberger A, Rosario M, Pittenger C, Leckman J. Meta-Analysis of the Symptom Structure of Obsessive-Compulsive Disorder. FOCUS The Journal Of Lifelong Learning In Psychiatry 2015, 13: 232-243. DOI: 10.1176/appi.focus.130209.
Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorderBloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Molecular Psychiatry 2009, 15: 850-855. PMID: 19468281, PMCID: PMC2888928, DOI: 10.1038/mp.2009.50.
Meta-Analysis of the Symptom Structure of Obsessive-Compulsive DisorderBloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-Analysis of the Symptom Structure of Obsessive-Compulsive Disorder. American Journal Of Psychiatry 2008, 165: 1532-1542. PMID: 18923068, PMCID: PMC3972003, DOI: 10.1176/appi.ajp.2008.08020320.
Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic DisordersBloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic Disorders. Journal Of The American Academy Of Child & Adolescent Psychiatry 2009, 48: 884-893. PMID: 19625978, PMCID: PMC3943246, DOI: 10.1097/chi.0b013e3181b26e9f.
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorderBloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry 2006, 11: 622-632. PMID: 16585942, DOI: 10.1038/sj.mp.4001823.
Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity DisorderFarhat L, Flores J, Avila-Quintero V, Polanczyk G, Cipriani A, Furukawa T, Bloch M, Cortese S. Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder. JAMA Psychiatry 2023, 81 PMID: 37878348, PMCID: PMC10600727, DOI: 10.1001/jamapsychiatry.2023.3985.
25.4 Pharmacologic Interventions for Trichotillomania and Excoriation DisorderBloch M, Farhat L, Olfson E. 25.4 Pharmacologic Interventions for Trichotillomania and Excoriation Disorder. Journal Of The American Academy Of Child & Adolescent Psychiatry 2023, 62: s363. DOI: 10.1016/j.jaac.2023.07.760.
25.1 Prevalence and Clinical Characteristics of Trichotillomania and Excoriation DisorderFarhat L, Bloch M, Olfson E. 25.1 Prevalence and Clinical Characteristics of Trichotillomania and Excoriation Disorder. Journal Of The American Academy Of Child & Adolescent Psychiatry 2023, 62: s362. DOI: 10.1016/j.jaac.2023.07.757.
Protocol description for a randomized controlled trial of fMRI neurofeedback for tics in adolescents with Tourette SyndromeAwasthi J, Harris-Starling C, Kalvin C, Pittman B, Park H, Bloch M, Fernandez T, Sukhodolsky D, Hampson M. Protocol description for a randomized controlled trial of fMRI neurofeedback for tics in adolescents with Tourette Syndrome. Psychiatry Research Neuroimaging 2023, 111692. PMID: 37673711, DOI: 10.1016/j.pscychresns.2023.111692.
The genetic epidemiology of obsessive-compulsive disorder: a systematic review and meta-analysisBlanco-Vieira T, Radua J, Marcelino L, Bloch M, Mataix-Cols D, do Rosário M. The genetic epidemiology of obsessive-compulsive disorder: a systematic review and meta-analysis. Translational Psychiatry 2023, 13: 230. PMID: 37380645, PMCID: PMC10307810, DOI: 10.1038/s41398-023-02433-2.
Pharmacological and Somatic Treatment Effects on Suicide in Adults: A Systematic Review and Meta-AnalysisWilkinson S, Diaz D, Rupp Z, Kidambi A, Ramirez K, Flores J, Avila‐Quintero V, Rhee T, Olfson M, Bloch M. Pharmacological and Somatic Treatment Effects on Suicide in Adults: A Systematic Review and Meta-Analysis. FOCUS The Journal Of Lifelong Learning In Psychiatry 2023, 21: 197-208. PMID: 37201149, PMCID: PMC10172559, DOI: 10.1176/appi.focus.23021006.
Prevalence and gender distribution of excoriation (skin-picking) disorder: A systematic review and meta-analysisFarhat L, Reid M, Bloch M, Olfson E. Prevalence and gender distribution of excoriation (skin-picking) disorder: A systematic review and meta-analysis. Journal Of Psychiatric Research 2023, 161: 412-418. PMID: 37023597, DOI: 10.1016/j.jpsychires.2023.03.034.
Revisiting best practices: a reflection on the online evaluation and treatment of ADHD and implications for future practiceRolison M, Bloch M. Revisiting best practices: a reflection on the online evaluation and treatment of ADHD and implications for future practice. Child And Adolescent Psychiatry And Mental Health 2023, 17: 43. PMID: 36978153, PMCID: PMC10043842, DOI: 10.1186/s13034-023-00593-z.
Characteristics of trichotillomania and excoriation disorder across the lifespanLin A, Farhat L, Flores J, Levine J, Fernandez T, Bloch M, Olfson E. Characteristics of trichotillomania and excoriation disorder across the lifespan. Psychiatry Research 2023, 322: 115120. PMID: 36842397, PMCID: PMC10023474, DOI: 10.1016/j.psychres.2023.115120.
The Relationship Between Acute Dissociative Effects Induced by Ketamine and Treatment Response in Adolescent Patients with Treatment-Resistant DepressionLineham A, Avila-Quintero V, Bloch M, Dwyer J. The Relationship Between Acute Dissociative Effects Induced by Ketamine and Treatment Response in Adolescent Patients with Treatment-Resistant Depression. Journal Of Child And Adolescent Psychopharmacology 2023, 33: 20-26. PMID: 36799961, DOI: 10.1089/cap.2022.0086.
Systematic review and meta-analysis: Season of birth and schizophrenia riskCoury S, Lombroso A, Avila-Quintero V, Taylor J, Flores J, Szejko N, Bloch M. Systematic review and meta-analysis: Season of birth and schizophrenia risk. Schizophrenia Research 2023, 252: 244-252. PMID: 36682315, DOI: 10.1016/j.schres.2022.12.016.
Characterization of human basal ganglia organoidsBrady M, Mariani J, Koca Y, Szekely A, King R, Bloch M, Landeros-Weisenberger A, Leckman J, Vaccarino F. Characterization of human basal ganglia organoids. Molecular Psychiatry 2022, 27: 4823-4823. PMID: 36536052, DOI: 10.1038/s41380-022-01914-y.
Mispatterning and interneuron deficit in Tourette Syndrome basal ganglia organoidsBrady M, Mariani J, Koca Y, Szekely A, King R, Bloch M, Landeros-Weisenberger A, Leckman J, Vaccarino F. Mispatterning and interneuron deficit in Tourette Syndrome basal ganglia organoids. Molecular Psychiatry 2022, 27: 5007-5019. PMID: 36447010, PMCID: PMC9949887, DOI: 10.1038/s41380-022-01880-5.
Sexual Orientation and Racial Bias in Relation to Medical Specialty.Zelin NS, Scott C, Avila-Quintero VJ, Curlin K, Flores JM, Bloch MH. Sexual Orientation and Racial Bias in Relation to Medical Specialty. Journal Of Homosexuality 2022, 1-26. PMID: 36269161, DOI: 10.1080/00918369.2022.2132441.
Editorial: Schools on the frontline of suicide preventionKamody RC, Bloch MH. Editorial: Schools on the frontline of suicide prevention. Journal Of Child Psychology And Psychiatry 2022, 63: 833-835. PMID: 35861181, DOI: 10.1111/jcpp.13663.
Prevalence and gender distribution of trichotillomania: A systematic review and meta-analysisThomson HA, Farhat LC, Olfson E, Levine JLS, Bloch MH. Prevalence and gender distribution of trichotillomania: A systematic review and meta-analysis. Journal Of Psychiatric Research 2022, 153: 73-81. PMID: 35802953, DOI: 10.1016/j.jpsychires.2022.06.058.
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled TrialDwyer J, Landeros-Weisenberger A, Johnson J, Londono Tobon A, Flores J, Nasir M, Couloures K, Sanacora G, Bloch M. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial. FOCUS The Journal Of Lifelong Learning In Psychiatry 2022, 20: 241-251. PMID: 37153136, PMCID: PMC10153503, DOI: 10.1176/appi.focus.22020004.
Phenomenology of Tics and Sensory UrgesLeckman J, Bloch M, Sukhodolsky D, Artukoğlu B, Scahill L, King R. Phenomenology of Tics and Sensory Urges. 2022, 6-25. DOI: 10.1093/med/9780197543214.003.0002.
Editorial: We Can Do Better: Meta-analysis Demonstrates Inequities in Psychotherapy Efficacy for Black ChildrenBloch MH, Finch K. Editorial: We Can Do Better: Meta-analysis Demonstrates Inequities in Psychotherapy Efficacy for Black Children. Journal Of The American Academy Of Child & Adolescent Psychiatry 2022, 61: 742-744. PMID: 35346785, DOI: 10.1016/j.jaac.2022.03.011.
Parental age and the risk of bipolar disorder in the offspring: A systematic review and meta‐analysisPolga N, de Barros P, Farhat LC, Almeida K, Bloch MH, Lafer B. Parental age and the risk of bipolar disorder in the offspring: A systematic review and meta‐analysis. Acta Psychiatrica Scandinavica 2022, 145: 568-577. PMID: 35188977, DOI: 10.1111/acps.13418.
Meta‐Analysis: Efficacy and Tolerability of Vesicular Monoamine Transporter Type 2 Inhibitors in the Treatment of Tic DisordersBehling E, Farhat LC, Landeros‐Weisenberger A, Bloch MH. Meta‐Analysis: Efficacy and Tolerability of Vesicular Monoamine Transporter Type 2 Inhibitors in the Treatment of Tic Disorders. Movement Disorders 2022, 37: 684-693. PMID: 35191552, DOI: 10.1002/mds.28957.
Pharmacological and somatic treatment effects on suicide in adults: A systematic review and meta‐analysisWilkinson ST, Diaz D, Rupp ZW, Kidambi A, Ramirez KL, Flores JM, Avila‐Quintero V, Rhee TG, Olfson M, Bloch MH. Pharmacological and somatic treatment effects on suicide in adults: A systematic review and meta‐analysis. Depression And Anxiety 2021, 39: 100-112. PMID: 34762330, DOI: 10.1002/da.23222.
Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive DisorderFarhat LC, Vattimo EFQ, Ramakrishnan D, Levine JLS, Johnson JA, Artukoglu BB, Landeros-Weisenberger A, Asbahr FR, Cepeda SL, Comer JS, Fatori D, Franklin ME, Freeman JB, Geller DA, Grant PJ, Goodman WK, Heyman I, Ivarsson T, Lenhard F, Lewin AB, Li F, Merlo LJ, Mohsenabadi H, Peris TS, Piacentini J, Rosa-Alcázar AI, Rosa-Alcázar À, Rozenman M, Sapyta JJ, Serlachius E, Shabani MJ, Shavitt RG, Small BJ, Skarphedinsson G, Swedo SE, Thomsen PH, Turner C, Weidle B, Miguel EC, Storch EA, Mataix-Cols D, Bloch MH. Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive Disorder. Journal Of The American Academy Of Child & Adolescent Psychiatry 2021, 61: 495-507. PMID: 34597773, DOI: 10.1016/j.jaac.2021.05.027.
Meta-Analysis: Pediatric Placebo Response in Depression Trials Does Not Replicate in Anxiety and Obsessive-Compulsive Disorder TrialsNasir M, Li F, Courley S, Olten B, Bloch MH. Meta-Analysis: Pediatric Placebo Response in Depression Trials Does Not Replicate in Anxiety and Obsessive-Compulsive Disorder Trials. Journal Of Child And Adolescent Psychopharmacology 2021, 31: 670-684. PMID: 34558984, DOI: 10.1089/cap.2021.0030.
Editorial: Money cannot buy happiness – but can it prevent depression? A commentary on Su et al.Nasir M, Bloch MH. Editorial: Money cannot buy happiness – but can it prevent depression? A commentary on Su et al. Journal Of Child Psychology And Psychiatry 2021, 62: 1047-1049. PMID: 34448198, DOI: 10.1111/jcpp.13507.
A Phase-2 Pilot Study of a Therapeutic Combination of Δ9-Tetrahydracannabinol and Palmitoylethanolamide for Adults With Tourette’s SyndromeBloch MH, Landeros-Weisenberger A, Johnson JA, Leckman JF. A Phase-2 Pilot Study of a Therapeutic Combination of Δ9-Tetrahydracannabinol and Palmitoylethanolamide for Adults With Tourette’s Syndrome. Journal Of Neuropsychiatry 2021, 33: 328-336. PMID: 34340527, DOI: 10.1176/appi.neuropsych.19080178.
Don’t Forget, Untreated Maternal Depression Poses Health Risks to the Child, TooBehling E, Bloch MH. Don’t Forget, Untreated Maternal Depression Poses Health Risks to the Child, Too. Biological Psychiatry 2021, 90: 212-213. PMID: 34325804, DOI: 10.1016/j.biopsych.2021.06.010.
Parental Age and the Risk for Alzheimer’s Disease in Offspring: Systematic Review and Meta-AnalysisSzejko N, Macul Ferreira de Barros P, Avila-Quintero VJ, Lombroso A, Bloch MH. Parental Age and the Risk for Alzheimer’s Disease in Offspring: Systematic Review and Meta-Analysis. Dementia And Geriatric Cognitive Disorders Extra 2021, 11: 140-150. PMID: 34178019, PMCID: PMC8216010, DOI: 10.1159/000515523.
Deficits in hippocampal-dependent memory across different rodent models of early life stress: systematic review and meta-analysisRocha M, Wang D, Avila-Quintero V, Bloch MH, Kaffman A. Deficits in hippocampal-dependent memory across different rodent models of early life stress: systematic review and meta-analysis. Translational Psychiatry 2021, 11: 231. PMID: 33879774, PMCID: PMC8058062, DOI: 10.1038/s41398-021-01352-4.
Correction to: Racial Implicit Associations in Psychiatric Diagnosis, Treatment, and Compliance ExpectationsLondono Tobon A, Flores JM, Taylor JH, Johnson I, Landeros-Weisenberger A, Aboiralor O, Avila-Quintero VJ, Bloch MH. Correction to: Racial Implicit Associations in Psychiatric Diagnosis, Treatment, and Compliance Expectations. Academic Psychiatry 2021, 45: 533-534. PMID: 33821450, DOI: 10.1007/s40596-021-01435-w.
Meta-Analysis: Hemodynamic Responses to Sub-anesthetic Doses of Ketamine in Patients With Psychiatric DisordersVankawala J, Naples G, Avila-Quintero VJ, Ramírez KL, Flores JM, Bloch MH, Dwyer JB. Meta-Analysis: Hemodynamic Responses to Sub-anesthetic Doses of Ketamine in Patients With Psychiatric Disorders. Frontiers In Psychiatry 2021, 12: 549080. PMID: 33841195, PMCID: PMC8024485, DOI: 10.3389/fpsyt.2021.549080.
Tourette SyndromeBloch M. Tourette Syndrome. 2021, 4877-4882. DOI: 10.1007/978-3-319-91280-6_1616.
TrichotillomaniaBloch M. Trichotillomania. 2021, 4916-4920. DOI: 10.1007/978-3-319-91280-6_1839.
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled TrialDwyer J, Landeros-Weisenberger A, Johnson J, Tobon A, Flores J, Nasir M, Couloures K, Sanacora G, Bloch M. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial. FOCUS The Journal Of Lifelong Learning In Psychiatry 2021, 20: 241-251. DOI: 10.1176/appi.focus.22020004.
FROM NEUROSCIENCE TO EVIDENCE-BASED TREATMENTS: AN UPDATE ON BODY-FOCUSED REPETITIVE BEHAVIORS RESEARCHOlfson E, Bloch M, Raikes J. FROM NEUROSCIENCE TO EVIDENCE-BASED TREATMENTS: AN UPDATE ON BODY-FOCUSED REPETITIVE BEHAVIORS RESEARCH. Journal Of The American Academy Of Child & Adolescent Psychiatry 2020, 59: s327. DOI: 10.1016/j.jaac.2020.07.782.
28.7 INTEGRATING CLINICAL AND RESEARCH TRAINING IN CHILD PSYCHIATRY: 15-YEAR OUTCOMES OF A FEDERALLY SUPPORTED PROGRAMCalhoun A, Bloch M, Stubbe D, Leckman J, Martin A. 28.7 INTEGRATING CLINICAL AND RESEARCH TRAINING IN CHILD PSYCHIATRY: 15-YEAR OUTCOMES OF A FEDERALLY SUPPORTED PROGRAM. Journal Of The American Academy Of Child & Adolescent Psychiatry 2020, 59: s205. DOI: 10.1016/j.jaac.2020.08.252.
13.3 THE AMOUNT AND QUALITY OF INTERACTIONS BETWEEN CLINICIANS AND BLACK INDIVIDUALS DURING CHILDHOOD PREDICTS RACE IMPLICIT ASSOCIATION SCORESAvila-Quintero V, Calhoun A, Flores J, Taylor J, Landeros A, Bloch M, Tobon A. 13.3 THE AMOUNT AND QUALITY OF INTERACTIONS BETWEEN CLINICIANS AND BLACK INDIVIDUALS DURING CHILDHOOD PREDICTS RACE IMPLICIT ASSOCIATION SCORES. Journal Of The American Academy Of Child & Adolescent Psychiatry 2020, 59: s183. DOI: 10.1016/j.jaac.2020.08.175.
13.1 CROSS-CULTURAL TREATMENT OF CHILD MENTAL HEALTH CONDITIONS: AN INVESTIGATION OF CHILD PSYCHIATRY IN JAPANJohnson I, Hamamoto Y, Bloch M. 13.1 CROSS-CULTURAL TREATMENT OF CHILD MENTAL HEALTH CONDITIONS: AN INVESTIGATION OF CHILD PSYCHIATRY IN JAPAN. Journal Of The American Academy Of Child & Adolescent Psychiatry 2020, 59: s182-s183. DOI: 10.1016/j.jaac.2020.08.173.
Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders StudyTaylor JH, Appel S, Eli M, Alexander-Bloch A, Maayan L, Gur RE, Bloch MH. Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders Study. Journal Of Child And Adolescent Psychopharmacology 2020, 31: 46-52. PMID: 32633541, PMCID: PMC7891207, DOI: 10.1089/cap.2020.0030.
Little Doubt That CBT Works for Pediatric OCDStorch EA, Peris TS, De Nadai A, Piacentini J, Bloch M, Cervin M, McGuire J, Farrell LJ, McCracken JT, McKay D, Riemann BC, Wagner AP, Franklin M, Schneider SC, Walkup JT, Williams L, Abramowitz JS, Stewart SE, Fitzgerald KD, Goodman WK. Little Doubt That CBT Works for Pediatric OCD. Journal Of The American Academy Of Child & Adolescent Psychiatry 2020, 59: 785-787. PMID: 32618273, DOI: 10.1016/j.jaac.2020.01.026.
Systematic review and meta-analysis: effects of maternal separation on anxiety-like behavior in rodentsWang D, Levine JLS, Avila-Quintero V, Bloch M, Kaffman A. Systematic review and meta-analysis: effects of maternal separation on anxiety-like behavior in rodents. Translational Psychiatry 2020, 10: 174. PMID: 32483128, PMCID: PMC7264128, DOI: 10.1038/s41398-020-0856-0.
Pharmacologic Treatment of Tardive Dyskinesia: A Meta-Analysis and Systematic Review.Artukoglu BB, Li F, Szejko N, Bloch MH. Pharmacologic Treatment of Tardive Dyskinesia: A Meta-Analysis and Systematic Review. The Journal Of Clinical Psychiatry 2020, 81 PMID: 32459404, DOI: 10.4088/jcp.19r12798.
Integrating clinical and research training in child psychiatry: fifteen-year outcomes of a federally supported programCalhoun A, Bloch MH, Stubbe D, Leckman JF, Martin A. Integrating clinical and research training in child psychiatry: fifteen-year outcomes of a federally supported program. Child And Adolescent Psychiatry And Mental Health 2020, 14: 21. PMID: 32467724, PMCID: PMC7227282, DOI: 10.1186/s13034-020-00328-4.
Meta-analysis: Pharmacologic Treatment of Restricted and Repetitive Behaviors in Autism Spectrum DisordersZhou MS, Nasir M, Farhat LC, Kook M, Artukoglu BB, Bloch MH. Meta-analysis: Pharmacologic Treatment of Restricted and Repetitive Behaviors in Autism Spectrum Disorders. Journal Of The American Academy Of Child & Adolescent Psychiatry 2020, 60: 35-45. PMID: 32387445, DOI: 10.1016/j.jaac.2020.03.007.
Chapter 39 Obsessive–compulsive disorderBloch M, Artukoglu B, Lennington J, Szuhay G, Lombroso P. Chapter 39 Obsessive–compulsive disorder. 2020, 663-674. DOI: 10.1016/b978-0-12-813866-3.00039-4.
Chapter 40 Tourette syndromeFasching L, Brady M, Bloch M, Lombroso P, Vaccarino F. Chapter 40 Tourette syndrome. 2020, 675-686. DOI: 10.1016/b978-0-12-813866-3.00040-0.
N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot StudyLi F, Welling MC, Johnson JA, Coughlin C, Mulqueen J, Jakubovski E, Coury S, Landeros-Weisenberger A, Bloch MH. N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study. Journal Of Child And Adolescent Psychopharmacology 2019, 30: 32-37. PMID: 31800306, PMCID: PMC7133418, DOI: 10.1089/cap.2019.0041.
Measuring Treatment Response in Pediatric Trichotillomania: A Meta-Analysis of Clinical TrialsFarhat LC, Olfson E, Levine JLS, Li F, Franklin ME, Lee HJ, Lewin AB, McGuire JF, Rahman O, Storch EA, Tolin DF, Zickgraf HF, Bloch MH. Measuring Treatment Response in Pediatric Trichotillomania: A Meta-Analysis of Clinical Trials. Journal Of Child And Adolescent Psychopharmacology 2019, 30: 306-315. PMID: 31794677, PMCID: PMC7476376, DOI: 10.1089/cap.2019.0103.
Selective Serotonin Reuptake Inhibitor Use During Pregnancy—Associated With but Not Causative of Autism in OffspringFlores JM, Avila-Quintero VJ, Bloch MH. Selective Serotonin Reuptake Inhibitor Use During Pregnancy—Associated With but Not Causative of Autism in Offspring. JAMA Psychiatry 2019, 76: 1225-1227. PMID: 31577332, DOI: 10.1001/jamapsychiatry.2019.2193.
Meta-analysis of placebo group dropout in adult antidepressant trialsLi F, Nasir M, Olten B, Bloch MH. Meta-analysis of placebo group dropout in adult antidepressant trials. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2019, 98: 109777. PMID: 31697973, DOI: 10.1016/j.pnpbp.2019.109777.
Meta-Analysis of Placebo Response in Adult Antidepressant TrialsLi F, Nasir M, Olten B, Bloch MH. Meta-Analysis of Placebo Response in Adult Antidepressant Trials. CNS Drugs 2019, 33: 971-980. PMID: 31573058, DOI: 10.1007/s40263-019-00662-y.
PEDIATRIC TRICHOTILLOMANIA: AN UPDATE ON SCREENING, GENETICS, AND TREATMENTBloch M, Olfson E, Stewart S. PEDIATRIC TRICHOTILLOMANIA: AN UPDATE ON SCREENING, GENETICS, AND TREATMENT. Journal Of The American Academy Of Child & Adolescent Psychiatry 2019, 58: s313-s314. DOI: 10.1016/j.jaac.2019.07.722.
44.3 EMERGING AND EVIDENCE-BASED TREATMENTS FOR TIC DISORDERSBloch M. 44.3 EMERGING AND EVIDENCE-BASED TREATMENTS FOR TIC DISORDERS. Journal Of The American Academy Of Child & Adolescent Psychiatry 2019, 58: s367. DOI: 10.1016/j.jaac.2019.07.898.
10.4 EVALUATION AND ASSESSMENT OF TRICHOTILLOMANIA ACROSS THE LIFESPANBloch M, Farhat L. 10.4 EVALUATION AND ASSESSMENT OF TRICHOTILLOMANIA ACROSS THE LIFESPAN. Journal Of The American Academy Of Child & Adolescent Psychiatry 2019, 58: s314. DOI: 10.1016/j.jaac.2019.07.726.
1.60 ANTIDEPRESSANT TREATMENT OF MDD IN PATIENTS WITH COMORBID ALCOHOL USE DISORDER: A META-ANALYSIS OF RANDOMIZED PLACEBO-CONTROLLED TRIALS WITH DISCUSSION OF PEDIATRIC IMPLICATIONSJohnson I, Shovestul B, Niciu M, Li F, Bloch M. 1.60 ANTIDEPRESSANT TREATMENT OF MDD IN PATIENTS WITH COMORBID ALCOHOL USE DISORDER: A META-ANALYSIS OF RANDOMIZED PLACEBO-CONTROLLED TRIALS WITH DISCUSSION OF PEDIATRIC IMPLICATIONS. Journal Of The American Academy Of Child & Adolescent Psychiatry 2019, 58: s166. DOI: 10.1016/j.jaac.2019.08.082.
1.4 TIME UNTIL CLINICAL IMPROVEMENT IN THE TREATMENT OF EARLY-ONSET SCHIZOPHRENIA SPECTRUM DISORDERS STUDY (TEOSS)Taylor J, Appel S, Eli M, Bloch M. 1.4 TIME UNTIL CLINICAL IMPROVEMENT IN THE TREATMENT OF EARLY-ONSET SCHIZOPHRENIA SPECTRUM DISORDERS STUDY (TEOSS). Journal Of The American Academy Of Child & Adolescent Psychiatry 2019, 58: s148. DOI: 10.1016/j.jaac.2019.08.026.
Antidepressants for Pediatric Patients.Dwyer JB, Bloch MH. Antidepressants for Pediatric Patients. Current Psychiatry 2019, 18: 26-42f. PMID: 31511767, PMCID: PMC6738970.
Randomized, Sham-Controlled Trial of Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Tics in Adolescents With Tourette SyndromeSukhodolsky DG, Walsh C, Koller WN, Eilbott J, Rance M, Fulbright RK, Zhao Z, Bloch MH, King R, Leckman JF, Scheinost D, Pittman B, Hampson M. Randomized, Sham-Controlled Trial of Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Tics in Adolescents With Tourette Syndrome. Biological Psychiatry 2019, 87: 1063-1070. PMID: 31668476, PMCID: PMC7015800, DOI: 10.1016/j.biopsych.2019.07.035.
Meta-analysis: Adulthood prevalence of Tourette syndromeLevine JLS, Szejko N, Bloch MH. Meta-analysis: Adulthood prevalence of Tourette syndrome. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2019, 95: 109675. PMID: 31220521, DOI: 10.1016/j.pnpbp.2019.109675.
F28. Whole-Exome Sequencing Study of TrichotillomaniaOlfson E, Bloch M, Fernandez T. F28. Whole-Exome Sequencing Study of Trichotillomania. Biological Psychiatry 2019, 85: s223. DOI: 10.1016/j.biopsych.2019.03.565.
S128. Expectancy and Ketamine’s Rapid Antidepressant Effect: A Meta-AnalysisWebler R, Wilkinson S, Kirwin D, Bloch M, Kitay B, Sanacora G. S128. Expectancy and Ketamine’s Rapid Antidepressant Effect: A Meta-Analysis. Biological Psychiatry 2019, 85: s346. DOI: 10.1016/j.biopsych.2019.03.879.
The impact of attention deficit hyperactivity disorder in obsessive‐compulsive disorder subjectsBlanco‐Vieira T, Santos M, Ferrão YA, Torres AR, Miguel EC, Bloch MH, Leckman JF, do Rosario MC. The impact of attention deficit hyperactivity disorder in obsessive‐compulsive disorder subjects. Depression And Anxiety 2019, 36: 533-542. PMID: 30990937, DOI: 10.1002/da.22898.
The Potential of Cannabinoid-Based Treatments in Tourette SyndromeArtukoglu BB, Bloch MH. The Potential of Cannabinoid-Based Treatments in Tourette Syndrome. CNS Drugs 2019, 33: 417-430. PMID: 30977108, DOI: 10.1007/s40263-019-00627-1.
Severe Illness Anxiety Treated by Integrating Inpatient Psychotherapy With Medical Care and Minimizing ReassuranceHiggins-Chen AT, Abdallah SB, Dwyer JB, Kaye AP, Angarita GA, Bloch MH. Severe Illness Anxiety Treated by Integrating Inpatient Psychotherapy With Medical Care and Minimizing Reassurance. Frontiers In Psychiatry 2019, 10: 150. PMID: 30967801, PMCID: PMC6438952, DOI: 10.3389/fpsyt.2019.00150.
Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis.Dobson ET, Bloch MH, Strawn JR. Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis. The Journal Of Clinical Psychiatry 2019, 80 PMID: 30753760, DOI: 10.4088/jcp.17r12064.
Trim the fat: the role of omega-3 fatty acids in psychopharmacologyNasir M, Bloch MH. Trim the fat: the role of omega-3 fatty acids in psychopharmacology. Therapeutic Advances In Psychopharmacology 2019, 9: 2045125319869791. PMID: 31489174, PMCID: PMC6713969, DOI: 10.1177/2045125319869791.
Andrea Kupfer Schneider David Kupfer Smart & Savvy: Negotiation Strategies in Academia 2017 Meadows Communications LLC Park City, UTBloch M. Andrea Kupfer Schneider David Kupfer Smart & Savvy: Negotiation Strategies in Academia 2017 Meadows Communications LLC Park City, UT. Journal Of The American Academy Of Child & Adolescent Psychiatry 2018, 57: 980-982. DOI: 10.1016/j.jaac.2018.10.007.
Systematic review and meta‐analysis: Dose–response curve of SSRIs and SNRIs in anxiety disordersJakubovski E, Johnson JA, Nasir M, Müller‐Vahl K, Bloch MH. Systematic review and meta‐analysis: Dose–response curve of SSRIs and SNRIs in anxiety disorders. Depression And Anxiety 2018, 36: 198-212. PMID: 30479005, DOI: 10.1002/da.22854.
Identifying standardized definitions of treatment response in trichotillomania: A meta-analysisFarhat LC, Olfson E, Li F, Telang S, Bloch MH. Identifying standardized definitions of treatment response in trichotillomania: A meta-analysis. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2018, 89: 446-455. PMID: 30336171, DOI: 10.1016/j.pnpbp.2018.10.009.
Exploring Retrospective Biases in Obsessive-Compulsive Disorder: an Experience-Sampling StudyMacLaren Kelly J, Kertz S, Simpson R, Bloch M, Pittenger C. Exploring Retrospective Biases in Obsessive-Compulsive Disorder: an Experience-Sampling Study. Journal Of Technology In Behavioral Science 2018, 4: 297-302. DOI: 10.1007/s41347-018-0078-y.
Pediatric TrichotillomaniaOlfson E, Bloch M, Piacentini J. Pediatric Trichotillomania. Journal Of The American Academy Of Child & Adolescent Psychiatry 2018, 57: s320. DOI: 10.1016/j.jaac.2018.07.805.
6.4 Ketamine: An Emerging Treatment for Adolescent DepressionBloch M, Dwyer J. 6.4 Ketamine: An Emerging Treatment for Adolescent Depression. Journal Of The American Academy Of Child & Adolescent Psychiatry 2018, 57: s130. DOI: 10.1016/j.jaac.2018.07.594.
4.3 Advances in the Pharmacological Treatments of Tic DisordersBloch M. 4.3 Advances in the Pharmacological Treatments of Tic Disorders. Journal Of The American Academy Of Child & Adolescent Psychiatry 2018, 57: s275. DOI: 10.1016/j.jaac.2018.07.637.
33.4 Pharmacological Treatments for Pediatric TrichotillomaniaBloch M. 33.4 Pharmacological Treatments for Pediatric Trichotillomania. Journal Of The American Academy Of Child & Adolescent Psychiatry 2018, 57: s321. DOI: 10.1016/j.jaac.2018.07.809.
Research Institute: Treatment Updates in Pediatric Depression and SuicidalityGlowinski A, Bloch M. Research Institute: Treatment Updates in Pediatric Depression and Suicidality. Journal Of The American Academy Of Child & Adolescent Psychiatry 2018, 57: s127. DOI: 10.1016/j.jaac.2018.07.582.
5.3 Ketamine Across the Lifespan: An Emerging Treatment for Depression and SuicidalityBloch M, Dwyer J. 5.3 Ketamine Across the Lifespan: An Emerging Treatment for Depression and Suicidality. Journal Of The American Academy Of Child & Adolescent Psychiatry 2018, 57: s127-s128. DOI: 10.1016/j.jaac.2018.07.585.
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)Banaschewski T, Belsham B, Bloch MH, Ferrin M, Johnson M, Kustow J, Robinson S, Zuddas A. Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD). Nutrition And Health 2018, 24: 279-284. PMID: 29921155, PMCID: PMC6291899, DOI: 10.1177/0260106018772170.
Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders StudyTaylor JH, Jakubovski E, Gabriel D, Bloch MH. Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study. Journal Of Child And Adolescent Psychopharmacology 2018, 28: 474-484. PMID: 29920116, PMCID: PMC6154761, DOI: 10.1089/cap.2017.0147.
Adam B. Lewin Eric A. Storch Understanding OCD: A Guide for Parents and Professionals 2017 Jessica Kingsley Publishers London, United KingdomArtukoglu B, Bloch M. Adam B. Lewin Eric A. Storch Understanding OCD: A Guide for Parents and Professionals 2017 Jessica Kingsley Publishers London, United Kingdom. Journal Of The American Academy Of Child & Adolescent Psychiatry 2018, 57: 443-445. DOI: 10.1016/j.jaac.2018.04.005.
Special Editorial: Open science and the Journal of Child Psychology & Psychiatry – next steps?Asarnow J, Bloch MH, Brandeis D, Burt S, Fearon P, Fombonne E, Green J, Gregory A, Gunnar M, Halperin JM, Hollis C, Jaffee S, Klump K, Landau S, Lesch K, Oldehinkel A, Peterson B, Ramchandani P, Sonuga‐Barke E, Stringaris A, Zeanah CH. Special Editorial: Open science and the Journal of Child Psychology & Psychiatry – next steps? Journal Of Child Psychology And Psychiatry 2018, 59: 826-827. PMID: 29806217, DOI: 10.1111/jcpp.12929.
Editorial: Can omega‐3 fatty acids improve executive functioning? Will this reduce ADHD and depression?Artukoglu BB, Bloch MH. Editorial: Can omega‐3 fatty acids improve executive functioning? Will this reduce ADHD and depression? Journal Of Child Psychology And Psychiatry 2018, 59: 615-617. PMID: 29808491, DOI: 10.1111/jcpp.12932.
A Systematic Review of Pharmacologic Treatments for School Refusal BehaviorTobon A, Reed MO, Taylor JH, Bloch MH. A Systematic Review of Pharmacologic Treatments for School Refusal Behavior. Journal Of Child And Adolescent Psychopharmacology 2018, 28: 368-378. PMID: 29741917, PMCID: PMC6909768, DOI: 10.1089/cap.2017.0160.
Time course of clinical change following neurofeedbackRance M, Walsh C, Sukhodolsky DG, Pittman B, Qiu M, Kichuk SA, Wasylink S, Koller WN, Bloch M, Gruner P, Scheinost D, Pittenger C, Hampson M. Time course of clinical change following neurofeedback. NeuroImage 2018, 181: 807-813. PMID: 29729393, PMCID: PMC6454268, DOI: 10.1016/j.neuroimage.2018.05.001.
Meta-analysis: Second generation antidepressants and headacheTelang S, Walton C, Olten B, Bloch MH. Meta-analysis: Second generation antidepressants and headache. Journal Of Affective Disorders 2018, 236: 60-68. PMID: 29715610, DOI: 10.1016/j.jad.2018.04.047.
Meta regression: Relationship between antipsychotic receptor binding profiles and side-effectsOlten B, Bloch MH. Meta regression: Relationship between antipsychotic receptor binding profiles and side-effects. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2018, 84: 272-281. PMID: 29410000, DOI: 10.1016/j.pnpbp.2018.01.023.
Meta-Analysis: Melatonin for the Treatment of Primary Sleep DisordersFerracioli-Oda E, Qawasmi A, Bloch MH. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. FOCUS The Journal Of Lifelong Learning In Psychiatry 2018, 16: 113-118. PMID: 32015706, PMCID: PMC6519571, DOI: 10.1176/appi.focus.16101.
Chapter 17 Managing a Child With OCD Who Is Treatment RefractoryBloch M. Chapter 17 Managing a Child With OCD Who Is Treatment Refractory. 2018, 329-356. DOI: 10.1016/b978-0-12-811427-8.00017-4.
Meta-analysis: Risk of dry mouth with second generation antidepressantsCappetta K, Beyer C, Johnson JA, Bloch MH. Meta-analysis: Risk of dry mouth with second generation antidepressants. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2017, 84: 282-293. PMID: 29274375, DOI: 10.1016/j.pnpbp.2017.12.012.
6.23 Predictors of Long-Term Risky Driving Behavior in the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)Johnson J, Jakubovski E, Reed M, Bloch M. 6.23 Predictors of Long-Term Risky Driving Behavior in the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (ADHD). Journal Of The American Academy Of Child & Adolescent Psychiatry 2017, 56: s284. DOI: 10.1016/j.jaac.2017.09.368.
2.1 Ketamine As a Treatment for Adolescent Major Depressive DisorderDwyer J, Bloch M. 2.1 Ketamine As a Treatment for Adolescent Major Depressive Disorder. Journal Of The American Academy Of Child & Adolescent Psychiatry 2017, 56: s176. DOI: 10.1016/j.jaac.2017.09.081.
6.3 Repetitive Behaviors and Obsessive-Compulsive Symptoms in Autism Spectrum DisordersBloch M. 6.3 Repetitive Behaviors and Obsessive-Compulsive Symptoms in Autism Spectrum Disorders. Journal Of The American Academy Of Child & Adolescent Psychiatry 2017, 56: s9. DOI: 10.1016/j.jaac.2017.07.035.
Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal StudyTaylor JH, Lebowitz ER, Jakubovski E, Coughlin CG, Silverman WK, Bloch MH. Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study. Journal Of Clinical Child & Adolescent Psychology 2017, 47: 266-281. PMID: 28956620, PMCID: PMC6191182, DOI: 10.1080/15374416.2017.1371028.
Efficacy of antipsychotics for irritability and aggression in children: a meta-analysisvan Schalkwyk GI, Lewis AS, Beyer C, Johnson J, van Rensburg S, Bloch MH. Efficacy of antipsychotics for irritability and aggression in children: a meta-analysis. Expert Review Of Neurotherapeutics 2017, 17: 1045-1053. PMID: 28847182, DOI: 10.1080/14737175.2017.1371012.
Meta‐analysis: Risk of hyperhidrosis with second‐generation antidepressantsBeyer C, Cappetta K, Johnson JA, Bloch MH. Meta‐analysis: Risk of hyperhidrosis with second‐generation antidepressants. Depression And Anxiety 2017, 34: 1134-1146. PMID: 28881483, DOI: 10.1002/da.22680.
Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover TrialTaylor JH, Landeros-Weisenberger A, Coughlin C, Mulqueen J, Johnson JA, Gabriel D, Reed MO, Jakubovski E, Bloch MH. Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial. Neuropsychopharmacology 2017, 43: 325-333. PMID: 28849779, PMCID: PMC5729569, DOI: 10.1038/npp.2017.194.
Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.Costa DLC, Diniz JB, Requena G, Joaquim MA, Pittenger C, Bloch MH, Miguel EC, Shavitt RG. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder. The Journal Of Clinical Psychiatry 2017, 78: e766-e773. PMID: 28617566, DOI: 10.4088/jcp.16m11101.
Predictors of Long-Term Risky Driving Behavior in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity DisorderJohnson JA, Jakubovski E, Reed MO, Bloch MH. Predictors of Long-Term Risky Driving Behavior in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder. Journal Of Child And Adolescent Psychopharmacology 2017, 27: 747-754. PMID: 28771386, PMCID: PMC5651934, DOI: 10.1089/cap.2017.0025.
Deep Brain Stimulation for Obsessive-Compulsive Disorder—ReplyHirschtritt ME, Bloch MH, Mathews CA. Deep Brain Stimulation for Obsessive-Compulsive Disorder—Reply. JAMA 2017, 318: 393-393. PMID: 28742903, DOI: 10.1001/jama.2017.7873.
Antipsychotics for aggression in adults: A meta-analysisvan Schalkwyk GI, Beyer C, Johnson J, Deal M, Bloch MH. Antipsychotics for aggression in adults: A meta-analysis. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2017, 81: 452-458. PMID: 28754408, DOI: 10.1016/j.pnpbp.2017.07.019.
Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis.Artukoglu BB, Beyer C, Zuloff-Shani A, Brener E, Bloch MH. Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis. Pain Physician 2017, 20: 353-362. PMID: 28727699.
Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis.Stuckelman ZD, Mulqueen JM, Ferracioli-Oda E, Cohen SC, Coughlin CG, Leckman JF, Bloch MH. Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis. The Journal Of Clinical Psychiatry 2017, 78: e648-e655. PMID: 28682529, DOI: 10.4088/jcp.15r10601.
Editorial: The continuing contributions of multimodal treatment of attention over nearly two decades to initial attention-deficit hyperactivity disorder pharmacotherapy and long-term clinical course.Bloch MH. Editorial: The continuing contributions of multimodal treatment of attention over nearly two decades to initial attention-deficit hyperactivity disorder pharmacotherapy and long-term clinical course. Journal Of Child Psychology And Psychiatry, And Allied Disciplines 2017, 58: 637-639. PMID: 28524461, DOI: 10.1111/jcpp.12755.
Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) studyGabriel D, Jakubovski E, Taylor JH, Artukoglu BB, Bloch MH. Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study. Psychiatry Research 2017, 255: 248-255. PMID: 28595147, DOI: 10.1016/j.psychres.2017.05.038.
The efficacy of benzodiazepines as acute anxiolytics in children: A meta‐analysisKuang H, Johnson JA, Mulqueen JM, Bloch MH. The efficacy of benzodiazepines as acute anxiolytics in children: A meta‐analysis. Depression And Anxiety 2017, 34: 888-896. PMID: 28504861, PMCID: PMC5629100, DOI: 10.1002/da.22643.
399 Ketamine and Guanfacine Effects on Activation and Connectivity during Working Memory: A Functional Magnetic Resonance Imaging InvestigationDriesen N, McCarthy G, Arnsten A, Morgan P, He G, Bloch M, Krystal J. 399 Ketamine and Guanfacine Effects on Activation and Connectivity during Working Memory: A Functional Magnetic Resonance Imaging Investigation. Biological Psychiatry 2017, 81: s163. DOI: 10.1016/j.biopsych.2017.02.416.
1002 Ketamine as a Treatment for Adolescent Major Depressive DisorderDwyer J, Sanacora G, Bloch M. 1002 Ketamine as a Treatment for Adolescent Major Depressive Disorder. Biological Psychiatry 2017, 81: s405. DOI: 10.1016/j.biopsych.2017.02.729.
Obsessive-Compulsive Disorder: Advances in Diagnosis and TreatmentHirschtritt ME, Bloch MH, Mathews CA. Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment. JAMA 2017, 317: 1358-1367. PMID: 28384832, DOI: 10.1001/jama.2017.2200.
Ketamine as a Treatment for Adolescent Depression: A Case ReportDwyer JB, Beyer C, Wilkinson ST, Ostroff RB, Qayyum Z, Bloch MH. Ketamine as a Treatment for Adolescent Depression: A Case Report. Journal Of The American Academy Of Child & Adolescent Psychiatry 2017, 56: 352-354. PMID: 28335880, DOI: 10.1016/j.jaac.2017.01.006.
Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive DisorderAdams TG, Bloch MH, Pittenger C. Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder. Journal Of Clinical Psychopharmacology 2017, 37: 269-271. PMID: 28121735, PMCID: PMC5321820, DOI: 10.1097/jcp.0000000000000659.
Predictors of Long-Term School-Based Behavioral Outcomes in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity DisorderReed MO, Jakubovski E, Johnson JA, Bloch MH. Predictors of Long-Term School-Based Behavioral Outcomes in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder. Journal Of Child And Adolescent Psychopharmacology 2017, 27: 296-309. PMID: 28253029, PMCID: PMC5439457, DOI: 10.1089/cap.2015.0168.
M13. Identifying Youths at Risk for Antipsychotic-Induced Weight Gain and Metabolic Dysfunction in the Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)Taylor J, Jakubovski E, Gabriel D, Bloch M. M13. Identifying Youths at Risk for Antipsychotic-Induced Weight Gain and Metabolic Dysfunction in the Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS). Schizophrenia Bulletin 2017, 43: s215-s216. PMCID: PMC5475770, DOI: 10.1093/schbul/sbx022.012.
Hippocampal Volume Changes Following Electroconvulsive Therapy: A Systematic Review and Meta-analysisWilkinson ST, Sanacora G, Bloch MH. Hippocampal Volume Changes Following Electroconvulsive Therapy: A Systematic Review and Meta-analysis. Biological Psychiatry Cognitive Neuroscience And Neuroimaging 2017, 2: 327-335. PMID: 28989984, PMCID: PMC5627663, DOI: 10.1016/j.bpsc.2017.01.011.
Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studiesLewis AS, van Schalkwyk GI, Bloch MH. Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2017, 75: 45-53. PMID: 28065843, PMCID: PMC5446073, DOI: 10.1016/j.pnpbp.2017.01.001.
Time Course and Predictors of Suicidal Ideation During Citalopram Treatment in the STAR*D Trial.Coughlin CG, Jakubovski E, Bloch MH. Time Course and Predictors of Suicidal Ideation During Citalopram Treatment in the STAR*D Trial. The Journal Of Clinical Psychiatry 2016, 77: e1262-e1269. PMID: 27631142, DOI: 10.4088/jcp.15m10075.
Commentary: Are alpha‐2 agonist really effective in children with tics with comorbid ADHD? A commentary on Whittington et al. (2016)Bloch MH. Commentary: Are alpha‐2 agonist really effective in children with tics with comorbid ADHD? A commentary on Whittington et al. (2016). Journal Of Child Psychology And Psychiatry 2016, 57: 1005-1007. PMID: 27535650, DOI: 10.1111/jcpp.12592.
Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive DisorderVarigonda AL, Jakubovski E, Bloch MH. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder. Journal Of The American Academy Of Child & Adolescent Psychiatry 2016, 55: 851-859.e2. PMID: 27663940, PMCID: PMC6944467, DOI: 10.1016/j.jaac.2016.07.768.
Addressing Difficulties in the Study of Dose-Response Relationships of SSRIs in Depression: Response to Hieronymus and ErikssonJakubovski E, Bloch MH. Addressing Difficulties in the Study of Dose-Response Relationships of SSRIs in Depression: Response to Hieronymus and Eriksson. American Journal Of Psychiatry 2016, 173: 836-838. PMID: 27477138, DOI: 10.1176/appi.ajp.2016.16030304r.
Editorial: Reducing adolescent suicideBloch MH. Editorial: Reducing adolescent suicide. Journal Of Child Psychology And Psychiatry 2016, 57: 773-774. PMID: 27320365, PMCID: PMC4975856, DOI: 10.1111/jcpp.12585.
Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.Issari Y, Jakubovski E, Bartley CA, Pittenger C, Bloch MH. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. The Journal Of Clinical Psychiatry 2016, 77: e605-11. PMID: 27249090, DOI: 10.4088/jcp.14r09758.
Systematic Review of Pharmacological and Behavioral Treatments for Skin Picking DisorderSchumer MC, Bartley CA, Bloch MH. Systematic Review of Pharmacological and Behavioral Treatments for Skin Picking Disorder. Journal Of Clinical Psychopharmacology 2016, 36: 147-152. PMID: 26872117, PMCID: PMC4930073, DOI: 10.1097/jcp.0000000000000462.
N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On TrialBloch MH, Panza KE, Yaffa A, Alvarenga PG, Jakubovski E, Mulqueen JM, Landeros-Weisenberger A, Leckman JF. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial. Journal Of Child And Adolescent Psychopharmacology 2016, 26: 327-334. PMID: 27027204, PMCID: PMC6445198, DOI: 10.1089/cap.2015.0109.
OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor bindingPittenger C, Adams TG, Gallezot JD, Crowley MJ, Nabulsi N, Ropchan J, Gao H, Kichuk SA, Simpson R, Billingslea E, Hannestad J, Bloch M, Mayes L, Bhagwagar Z, Carson RE. OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding. Journal Of Affective Disorders 2016, 196: 87-96. PMID: 26919057, PMCID: PMC4808438, DOI: 10.1016/j.jad.2016.02.021.
Family accommodation in obsessive-compulsive and anxiety disorders: a five-year updateLebowitz ER, Panza KE, Bloch MH. Family accommodation in obsessive-compulsive and anxiety disorders: a five-year update. Expert Review Of Neurotherapeutics 2015, 16: 45-53. PMID: 26613396, PMCID: PMC4895189, DOI: 10.1586/14737175.2016.1126181.
Anxiety Disorder-Specific Predictors of Treatment Outcome in the Coordinated Anxiety Learning and Management (CALM) TrialJakubovski E, Bloch MH. Anxiety Disorder-Specific Predictors of Treatment Outcome in the Coordinated Anxiety Learning and Management (CALM) Trial. Psychiatric Quarterly 2015, 87: 445-464. PMID: 26563229, DOI: 10.1007/s11126-015-9399-6.
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive DisorderJakubovski E, Varigonda AL, Freemantle N, Taylor MJ, Bloch MH. Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder. American Journal Of Psychiatry 2015, 173: 174-183. PMID: 26552940, PMCID: PMC4975858, DOI: 10.1176/appi.ajp.2015.15030331.
Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity DisorderCoughlin CG, Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Bloch MH. Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder. Journal Of Child And Adolescent Psychopharmacology 2015, 25: 611-617. PMID: 26402485, PMCID: PMC4617411, DOI: 10.1089/cap.2015.0075.
Prognostic subgroups for remission, response, and treatment continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) trial.Jakubovski E, Carlson JP, Bloch MH. Prognostic subgroups for remission, response, and treatment continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) trial. The Journal Of Clinical Psychiatry 2015, 76: 1535-45. PMID: 26581028, DOI: 10.4088/jcp.14m09320.
Tic disordersLeckman J, Bloch M. Tic disorders. 2015, 757-773. DOI: 10.1002/9781118381953.ch56.
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial.Pittenger C, Bloch MH, Wasylink S, Billingslea E, Simpson R, Jakubovski E, Kelmendi B, Sanacora G, Coric V. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial. The Journal Of Clinical Psychiatry 2015, 76: 1075-84. PMID: 26214725, PMCID: PMC4560666, DOI: 10.4088/jcp.14m09123.
Meta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled TrialsCohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Coughlin CG, Leckman JF, Bloch MH. Meta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials. Journal Of The American Academy Of Child & Adolescent Psychiatry 2015, 54: 728-736. PMID: 26299294, DOI: 10.1016/j.jaac.2015.06.011.
LONG‐TERM OUTCOME IN PEDIATRIC TRICHOTILLOMANIASchumer MC, Panza KE, Mulqueen JM, Jakubovski E, Bloch MH. LONG‐TERM OUTCOME IN PEDIATRIC TRICHOTILLOMANIA. Depression And Anxiety 2015, 32: 737-743. PMID: 26139231, PMCID: PMC4591183, DOI: 10.1002/da.22390.
Challenges of Fertility Sparing Ovarian Surgery Imposed by Krukenberg Tumors in PregnancyBloch MH, Elsarrag RZ, Elsarrag MZ, Salih SM. Challenges of Fertility Sparing Ovarian Surgery Imposed by Krukenberg Tumors in Pregnancy. Clinical Medical Reviews And Case Reports 2015, 2: 4. PMID: 26366440, PMCID: PMC4563814, DOI: 10.23937/2378-3656/1410041.
Obsessive–compulsive symptoms are associated with psychiatric comorbidities, behavioral and clinical problems: a population-based study of Brazilian school childrenAlvarenga PG, do Rosario MC, Cesar RC, Manfro GG, Moriyama TS, Bloch MH, Shavitt RG, Hoexter MQ, Coughlin CG, Leckman JF, Miguel EC. Obsessive–compulsive symptoms are associated with psychiatric comorbidities, behavioral and clinical problems: a population-based study of Brazilian school children. European Child & Adolescent Psychiatry 2015, 25: 175-182. PMID: 26015374, DOI: 10.1007/s00787-015-0723-3.
Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive DisorderVarigonda AL, Jakubovski E, Taylor MJ, Freemantle N, Coughlin C, Bloch MH. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder. Journal Of The American Academy Of Child & Adolescent Psychiatry 2015, 54: 557-564. PMID: 26088660, DOI: 10.1016/j.jaac.2015.05.004.
Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in PregnancyCoughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy. Obstetrics And Gynecology 2015, 125: 1224-1235. PMID: 25932852, PMCID: PMC4418034, DOI: 10.1097/aog.0000000000000759.
Obsessive-Compulsive Disorders in ChildhoodLeckman J, Bloch M. Obsessive-Compulsive Disorders in Childhood. 2015, 1150-1155. DOI: 10.1007/978-3-642-36172-2_124.
TrichotillomaniaBloch M. Trichotillomania. 2015, 1751-1754. DOI: 10.1007/978-3-642-36172-2_383.
Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trialTaylor JH, Jakubovski E, Bloch MH. Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial. Journal Of Psychiatric Research 2015, 65: 154-165. PMID: 25896121, PMCID: PMC4492801, DOI: 10.1016/j.jpsychires.2015.03.020.
Mr Jakubovski and Dr Bloch reply.Jakubovski E, Bloch MH. Mr Jakubovski and Dr Bloch reply. The Journal Of Clinical Psychiatry 2015, 76: 327-8. PMID: 25830452, DOI: 10.4088/jcp.14lr09483a.
Obsessive-compulsive symptom dimensions in a population-based, cross-sectional sample of school-aged childrenAlvarenga PG, Cesar RC, Leckman JF, Moriyama TS, Torres AR, Bloch MH, Coughlin CG, Hoexter MQ, Manfro GG, Polanczyk GV, Miguel EC, do Rosario MC. Obsessive-compulsive symptom dimensions in a population-based, cross-sectional sample of school-aged children. Journal Of Psychiatric Research 2015, 62: 108-114. PMID: 25702286, DOI: 10.1016/j.jpsychires.2015.01.018.
Assessment and Management of Treatment-Refractory Obsessive-Compulsive Disorder in ChildrenBloch MH, Storch EA. Assessment and Management of Treatment-Refractory Obsessive-Compulsive Disorder in Children. Journal Of The American Academy Of Child & Adolescent Psychiatry 2015, 54: 251-262. PMID: 25791142, PMCID: PMC4460245, DOI: 10.1016/j.jaac.2015.01.011.
Chapter 106 Obsessive–Compulsive DisorderBloch M, Lennington J, Szuhay G, Lombroso P. Chapter 106 Obsessive–Compulsive Disorder. 2015, 1301-1310. DOI: 10.1016/b978-0-12-410529-4.00106-6.
Chapter 107 Tourette SyndromeLennington J, Bloch M, Scahill L, Szuhay G, Lombroso P, Vaccarino F. Chapter 107 Tourette Syndrome. 2015, 1311-1320. DOI: 10.1016/b978-0-12-410529-4.00107-8.
Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.Kelly JM, Jakubovski E, Bloch MH. Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial. The Journal Of Clinical Psychiatry 2014, 76: 267-78. PMID: 25562579, PMCID: PMC4930076, DOI: 10.4088/jcp.13m08922.
Hats Off: Journal Awards 2014Martin A, Joshi P, Bloch M, Riddle M, Rogers C. Hats Off: Journal Awards 2014. Journal Of The American Academy Of Child & Adolescent Psychiatry 2014, 53: 1345-1347. DOI: 10.1016/j.jaac.2014.09.013.
Cross-Disorder Genome-Wide Analyses Suggest a Complex Genetic Relationship Between Tourette’s Syndrome and OCDYu D, Mathews CA, Scharf JM, Neale BM, Davis LK, Gamazon ER, Derks EM, Evans P, Edlund CK, Crane J, Fagerness JA, Osiecki L, Gallagher P, Gerber G, Haddad S, Illmann C, McGrath LM, Mayerfeld C, Arepalli S, Barlassina C, Barr CL, Bellodi L, Benarroch F, Berrió GB, Bienvenu OJ, Black DW, Bloch MH, Brentani H, Bruun RD, Budman CL, Camarena B, Campbell DD, Cappi C, Silgado JC, Cavallini MC, Chavira DA, Chouinard S, Cook EH, Cookson MR, Coric V, Cullen B, Cusi D, Delorme R, Denys D, Dion Y, Eapen V, Egberts K, Falkai P, Fernandez T, Fournier E, Garrido H, Geller D, Gilbert DL, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Grünblatt E, Hardy J, Heiman GA, Hemmings SM, Herrera LD, Hezel DM, Hoekstra PJ, Jankovic J, Kennedy JL, King RA, Konkashbaev AI, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Lupoli S, Macciardi F, Maier W, Manunta P, Marconi M, McCracken JT, Mesa Restrepo SC, Moessner R, Moorjani P, Morgan J, Muller H, Murphy DL, Naarden AL, Nurmi E, Ochoa WC, Ophoff RA, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner T, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosário MC, Rosenberg D, Ruhrmann S, Sabatti C, Salvi E, Sampaio AS, Samuels J, Sandor P, Service SK, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Turiel M, Valencia Duarte AV, Vallada H, Veenstra-VanderWeele J, Walitza S, Wang Y, Weale M, Weiss R, Wendland JR, Westenberg HG, Shugart YY, Hounie AG, Miguel EC, Nicolini H, Wagner M, Ruiz-Linares A, Cath DC, McMahon W, Posthuma D, Oostra BA, Nestadt G, Rouleau GA, Purcell S, Jenike MA, Heutink P, Hanna GL, Conti DV, Arnold PD, Freimer NB, Stewart SE, Knowles JA, Cox NJ, Pauls DL. Cross-Disorder Genome-Wide Analyses Suggest a Complex Genetic Relationship Between Tourette’s Syndrome and OCD. American Journal Of Psychiatry 2014, 172: 82-93. PMID: 25158072, PMCID: PMC4282594, DOI: 10.1176/appi.ajp.2014.13101306.
Nutritional Supplements for the Treatment of ADHDBloch MH, Mulqueen J. Nutritional Supplements for the Treatment of ADHD. Child And Adolescent Psychiatric Clinics Of North America 2014, 23: 883-897. PMID: 25220092, PMCID: PMC4170184, DOI: 10.1016/j.chc.2014.05.002.
Pharmacological Treatment of Obsessive-Compulsive DisorderPittenger C, Bloch MH. Pharmacological Treatment of Obsessive-Compulsive Disorder. Psychiatric Clinics Of North America 2014, 37: 375-391. PMID: 25150568, PMCID: PMC4143776, DOI: 10.1016/j.psc.2014.05.006.
A meta-analysis of computerized cognitive-behavioral therapy for the treatment of DSM-5 anxiety disorders.Adelman CB, Panza KE, Bartley CA, Bontempo A, Bloch MH. A meta-analysis of computerized cognitive-behavioral therapy for the treatment of DSM-5 anxiety disorders. The Journal Of Clinical Psychiatry 2014, 75: e695-704. PMID: 25093485, DOI: 10.4088/jcp.13r08894.
In Vivo Ketamine-Induced Changes in [11C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5DeLorenzo C, DellaGioia N, Bloch M, Sanacora G, Nabulsi N, Abdallah C, Yang J, Wen R, Mann JJ, Krystal JH, Parsey RV, Carson RE, Esterlis I. In Vivo Ketamine-Induced Changes in [11C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5. Biological Psychiatry 2014, 77: 266-275. PMID: 25156701, PMCID: PMC4277907, DOI: 10.1016/j.biopsych.2014.06.024.
Copy Number Variation in Obsessive-Compulsive Disorder and Tourette Syndrome: A Cross-Disorder StudyMcGrath LM, Yu D, Marshall C, Davis LK, Thiruvahindrapuram B, Li B, Cappi C, Gerber G, Wolf A, Schroeder FA, Osiecki L, O'Dushlaine C, Kirby A, Illmann C, Haddad S, Gallagher P, Fagerness JA, Barr CL, Bellodi L, Benarroch F, Bienvenu OJ, Black DW, Bloch MH, Bruun RD, Budman CL, Camarena B, Cath DC, Cavallini MC, Chouinard S, Coric V, Cullen B, Delorme R, Denys D, Derks EM, Dion Y, Rosário MC, Eapen V, Evans P, Falkai P, Fernandez TV, Garrido H, Geller D, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Grünblatt E, Heiman GA, Hemmings SM, Herrera LD, Hounie AG, Jankovic J, Kennedy JL, King RA, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Lochner C, Lowe TL, Lyon GJ, Macciardi F, Maier W, McCracken JT, McMahon W, Murphy DL, Naarden AL, Neale BM, Nurmi E, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Reus VI, Richter MA, Riddle M, Robertson MM, Rosenberg D, Rouleau GA, Ruhrmann S, Sampaio AS, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Tischfield JA, Vallada H, Veenstra-VanderWeele J, Walitza S, Wang Y, Wendland JR, Shugart YY, Miguel EC, Nicolini H, Oostra BA, Moessner R, Wagner M, Ruiz-Linares A, Heutink P, Nestadt G, Freimer N, Petryshen T, Posthuma D, Jenike MA, Cox NJ, Hanna GL, Brentani H, Scherer SW, Arnold PD, Stewart SE, Mathews CA, Knowles JA, Cook EH, Pauls DL, Wang K, Scharf JM. Copy Number Variation in Obsessive-Compulsive Disorder and Tourette Syndrome: A Cross-Disorder Study. Journal Of The American Academy Of Child & Adolescent Psychiatry 2014, 53: 910-919. PMID: 25062598, PMCID: PMC4218748, DOI: 10.1016/j.jaac.2014.04.022.
Meta-analysis: hoarding symptoms associated with poor treatment outcome in obsessive–compulsive disorderBloch MH, Bartley CA, Zipperer L, Jakubovski E, Landeros-Weisenberger A, Pittenger C, Leckman JF. Meta-analysis: hoarding symptoms associated with poor treatment outcome in obsessive–compulsive disorder. Molecular Psychiatry 2014, 19: 1025-1030. PMID: 24912494, PMCID: PMC4169729, DOI: 10.1038/mp.2014.50.
Histidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and MiceBaldan L, Williams K, Gallezot J, Pogorelov V, Rapanelli M, Crowley M, Anderson G, Loring E, Gorczyca R, Billingslea E, Wasylink S, Panza K, Ercan-Sencicek A, Krusong K, Leventhal B, Ohtsu H, Bloch M, Hughes Z, Krystal J, Mayes L, de Araujo I, Ding Y, State M, Pittenger C. Histidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and Mice. Neuron 2014, 82: 1186-1187. DOI: 10.1016/j.neuron.2014.05.023.
Prognostic subgroups for citalopram response in the STAR*D trial.Jakubovski E, Bloch MH. Prognostic subgroups for citalopram response in the STAR*D trial. The Journal Of Clinical Psychiatry 2014, 75: 738-47. PMID: 24912106, PMCID: PMC4471174, DOI: 10.4088/jcp.13m08727.
Tic DisordersKing R, Bloch M, Sukhodolsky D, Leckman J. Tic Disorders. 2014 DOI: 10.1176/appi.books.9781585625048.gg06.
TrichotillomaniaBloch M. Trichotillomania. 2014, 1-5. DOI: 10.1007/978-3-642-27772-6_383-2.
Obsessive-Compulsive Anxiety Disorders in ChildhoodLeckman J, Bloch M. Obsessive-Compulsive Anxiety Disorders in Childhood. 2014, 1-6. DOI: 10.1007/978-3-642-27772-6_124-2.
Clinical features of Tourette syndrome and tic disordersLeckman JF, King RA, Bloch MH. Clinical features of Tourette syndrome and tic disorders. Journal Of Obsessive-Compulsive And Related Disorders 2014, 3: 372-379. PMID: 30197854, PMCID: PMC6124690, DOI: 10.1016/j.jocrd.2014.03.004.
Meta-Analysis and Moderator Analysis: Can the Field Develop Further?Bloch MH. Meta-Analysis and Moderator Analysis: Can the Field Develop Further? Journal Of The American Academy Of Child & Adolescent Psychiatry 2014, 53: 135-137. PMID: 24472248, PMCID: PMC4471847, DOI: 10.1016/j.jaac.2013.12.001.
Histidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and MiceBaldan LC, Williams KA, Gallezot JD, Pogorelov V, Rapanelli M, Crowley M, Anderson GM, Loring E, Gorczyca R, Billingslea E, Wasylink S, Panza KE, Ercan-Sencicek AG, Krusong K, Leventhal BL, Ohtsu H, Bloch MH, Hughes ZA, Krystal JH, Mayes L, de Araujo I, Ding YS, State MW, Pittenger C. Histidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and Mice. Neuron 2014, 81: 77-90. PMID: 24411733, PMCID: PMC3894588, DOI: 10.1016/j.neuron.2013.10.052.
Meta-Analysis: Melatonin for the Treatment of Primary Sleep DisordersFerracioli-Oda E, Qawasmi A, Bloch M. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. FOCUS The Journal Of Lifelong Learning In Psychiatry 2014, 12: 73-79. DOI: 10.1176/appi.focus.12.1.73.
Global Resting-State Functional Magnetic Resonance Imaging Analysis Identifies Frontal Cortex, Striatal, and Cerebellar Dysconnectivity in Obsessive-Compulsive DisorderAnticevic A, Hu S, Zhang S, Savic A, Billingslea E, Wasylink S, Repovs G, Cole MW, Bednarski S, Krystal JH, Bloch MH, Li CS, Pittenger C. Global Resting-State Functional Magnetic Resonance Imaging Analysis Identifies Frontal Cortex, Striatal, and Cerebellar Dysconnectivity in Obsessive-Compulsive Disorder. Biological Psychiatry 2013, 75: 595-605. PMID: 24314349, PMCID: PMC3969771, DOI: 10.1016/j.biopsych.2013.10.021.
Cognitive-Behavioral Therapy for Anxiety in Children With High-Functioning Autism: A Meta-analysisSukhodolsky DG, Bloch MH, Panza KE, Reichow B. Cognitive-Behavioral Therapy for Anxiety in Children With High-Functioning Autism: A Meta-analysis. Pediatrics 2013, 132: e1341-e1350. PMID: 24167175, PMCID: PMC3813396, DOI: 10.1542/peds.2013-1193.
Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic ArchitectureDavis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, Neale BM, Yang J, Lee SH, Evans P, Barr CL, Bellodi L, Benarroch F, Berrio GB, Bienvenu OJ, Bloch MH, Blom RM, Bruun RD, Budman CL, Camarena B, Campbell D, Cappi C, Silgado J, Cath DC, Cavallini MC, Chavira DA, Chouinard S, Conti DV, Cook EH, Coric V, Cullen BA, Deforce D, Delorme R, Dion Y, Edlund CK, Egberts K, Falkai P, Fernandez TV, Gallagher PJ, Garrido H, Geller D, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Haddad S, Heiman GA, Hemmings SM, Hounie AG, Illmann C, Jankovic J, Jenike MA, Kennedy JL, King RA, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Macciardi F, McCracken JT, McGrath LM, Restrepo S, Moessner R, Morgan J, Muller H, Murphy DL, Naarden AL, Ochoa WC, Ophoff RA, Osiecki L, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner TJ, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosàrio MC, Rosenberg D, Rouleau GA, Ruhrmann S, Ruiz-Linares A, Sampaio AS, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Duarte A, Vallada H, Van Nieuwerburgh F, Veenstra-VanderWeele J, Walitza S, Wang Y, Wendland JR, Westenberg HG, Shugart YY, Miguel EC, McMahon W, Wagner M, Nicolini H, Posthuma D, Hanna GL, Heutink P, Denys D, Arnold PD, Oostra BA, Nestadt G, Freimer NB, Pauls DL, Wray NR, Stewart SE, Mathews CA, Knowles JA, Cox NJ, Scharf JM. Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture. PLOS Genetics 2013, 9: e1003864. PMID: 24204291, PMCID: PMC3812053, DOI: 10.1371/journal.pgen.1003864.
Meta-AnalysisMulqueen JM, Bartley CA, Bloch MH. Meta-Analysis. Journal Of Attention Disorders 2013, 19: 118-124. PMID: 24071773, DOI: 10.1177/1087054713504135.
Meta-analysis: pharmacological treatment of pathological gamblingBartley CA, Bloch MH. Meta-analysis: pharmacological treatment of pathological gambling. Expert Review Of Neurotherapeutics 2013, 13: 887-894. PMID: 23952195, DOI: 10.1586/14737175.2013.814938.
Brain mechanisms for prepulse inhibition in adults with Tourette syndrome: Initial findingsZebardast N, Crowley MJ, Bloch MH, Mayes LC, Wyk BV, Leckman JF, Pelphrey KA, Swain JE. Brain mechanisms for prepulse inhibition in adults with Tourette syndrome: Initial findings. Psychiatry Research 2013, 214: 33-41. PMID: 23916249, PMCID: PMC3932431, DOI: 10.1016/j.pscychresns.2013.05.009.
The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and ConnectivityDriesen NR, McCarthy G, Bhagwagar Z, Bloch MH, Calhoun VD, D'Souza DC, Gueorguieva R, He G, Leung HC, Ramani R, Anticevic A, Suckow RF, Morgan PT, Krystal JH. The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity. Neuropsychopharmacology 2013, 38: 2613-2622. PMID: 23856634, PMCID: PMC3828532, DOI: 10.1038/npp.2013.170.
Phenomenology of Tics and Sensory Urges: The Self Under SiegeLeckman J, Bloch M, Sukhodolsky D, Scahill L, King R. Phenomenology of Tics and Sensory Urges: The Self Under Siege. 2013, 3-25. DOI: 10.1093/med/9780199796267.003.0001.
Tourette Syndrome and Tic DisordersWilliams K, Bloch M, State M, Pittenger C. Tourette Syndrome and Tic Disorders. 2013, 1048-1060. DOI: 10.1093/med/9780199934959.003.0079.
Meta-Analysis: Melatonin for the Treatment of Primary Sleep DisordersFerracioli-Oda E, Qawasmi A, Bloch MH. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLOS ONE 2013, 8: e63773. PMID: 23691095, PMCID: PMC3656905, DOI: 10.1371/journal.pone.0063773.
Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive–compulsive disorder and a history of major depressive disorderNiciu MJ, Grunschel B, Corlett PR, Pittenger C, Bloch MH. Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive–compulsive disorder and a history of major depressive disorder. Journal Of Psychopharmacology 2013, 27: 651-654. PMID: 23676198, DOI: 10.1177/0269881113486718.
Meta-analysis: Aerobic exercise for the treatment of anxiety disordersBartley CA, Hay M, Bloch MH. Meta-analysis: Aerobic exercise for the treatment of anxiety disorders. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2013, 45: 34-39. PMID: 23643675, DOI: 10.1016/j.pnpbp.2013.04.016.
LONG‐TERM OUTCOME IN ADULTS WITH OBSESSIVE‐COMPULSIVE DISORDERBloch MH, Green C, Kichuk SA, Dombrowski PA, Wasylink S, Billingslea E, Landeros‐Weisenberger A, Kelmendi B, Goodman WK, Leckman JF, Coric V, Pittenger C. LONG‐TERM OUTCOME IN ADULTS WITH OBSESSIVE‐COMPULSIVE DISORDER. Depression And Anxiety 2013, 30: 716-722. PMID: 23532944, PMCID: PMC3932438, DOI: 10.1002/da.22103.
Systematic Review and Meta-analysis of Pharmacological Treatment of the Symptoms of Attention-Deficit/Hyperactivity Disorder in Children with Pervasive Developmental DisordersReichow B, Volkmar FR, Bloch MH. Systematic Review and Meta-analysis of Pharmacological Treatment of the Symptoms of Attention-Deficit/Hyperactivity Disorder in Children with Pervasive Developmental Disorders. Journal Of Autism And Developmental Disorders 2013, 43: 2435-2441. PMID: 23468071, PMCID: PMC3787525, DOI: 10.1007/s10803-013-1793-z.
N-Acetylcysteine in the Treatment of Pediatric Trichotillomania: A Randomized, Double-Blind, Placebo-Controlled Add-On TrialBloch MH, Panza KE, Grant JE, Pittenger C, Leckman JF. N-Acetylcysteine in the Treatment of Pediatric Trichotillomania: A Randomized, Double-Blind, Placebo-Controlled Add-On Trial. Journal Of The American Academy Of Child & Adolescent Psychiatry 2013, 52: 231-240. PMID: 23452680, PMCID: PMC3745012, DOI: 10.1016/j.jaac.2012.12.020.
Age and Gender Correlates of Pulling in Pediatric TrichotillomaniaPanza KE, Pittenger C, Bloch MH. Age and Gender Correlates of Pulling in Pediatric Trichotillomania. Journal Of The American Academy Of Child & Adolescent Psychiatry 2013, 52: 241-249. PMID: 23452681, PMCID: PMC3745006, DOI: 10.1016/j.jaac.2012.12.019.
Symptom dimensions are associated with age of onset and clinical course of obsessive–compulsive disorderKichuk SA, Torres AR, Fontenelle LF, Rosário MC, Shavitt RG, Miguel EC, Pittenger C, Bloch MH. Symptom dimensions are associated with age of onset and clinical course of obsessive–compulsive disorder. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2013, 44: 233-239. PMID: 23410525, PMCID: PMC3654083, DOI: 10.1016/j.pnpbp.2013.02.003.
Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humansDriesen NR, McCarthy G, Bhagwagar Z, Bloch M, Calhoun V, D'Souza DC, Gueorguieva R, He G, Ramachandran R, Suckow RF, Anticevic A, Morgan PT, Krystal JH. Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Molecular Psychiatry 2013, 18: 1199-1204. PMID: 23337947, PMCID: PMC3646075, DOI: 10.1038/mp.2012.194.
Meta-analysis of LCPUFA Supplementation of Infant Formula and Visual AcuityQawasmi A, Landeros-Weisenberger A, Bloch MH. Meta-analysis of LCPUFA Supplementation of Infant Formula and Visual Acuity. Pediatrics 2013, 131: e262-e272. PMID: 23248232, PMCID: PMC3529943, DOI: 10.1542/peds.2012-0517.
TrichotillomaniaBloch M. Trichotillomania. 2013, 3182-3186. DOI: 10.1007/978-1-4419-1698-3_1839.
Tourette SyndromeBloch M. Tourette Syndrome. 2013, 3144-3149. DOI: 10.1007/978-1-4419-1698-3_1616.
Clinical assessment of Tourette syndrome and tic disordersCohen SC, Leckman JF, Bloch MH. Clinical assessment of Tourette syndrome and tic disorders. Neuroscience & Biobehavioral Reviews 2012, 37: 997-1007. PMID: 23206664, PMCID: PMC3674220, DOI: 10.1016/j.neubiorev.2012.11.013.
Systematic review: Pharmacological treatment of tic disorders – Efficacy of antipsychotic and alpha-2 adrenergic agonist agentsWeisman H, Qureshi IA, Leckman JF, Scahill L, Bloch MH. Systematic review: Pharmacological treatment of tic disorders – Efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neuroscience & Biobehavioral Reviews 2012, 37: 1162-1171. PMID: 23099282, PMCID: PMC3674207, DOI: 10.1016/j.neubiorev.2012.09.008.
NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophreniaAnticevic A, Gancsos M, Murray JD, Repovs G, Driesen NR, Ennis DJ, Niciu MJ, Morgan PT, Surti TS, Bloch MH, Ramani R, Smith MA, Wang XJ, Krystal JH, Corlett PR. NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proceedings Of The National Academy Of Sciences Of The United States Of America 2012, 109: 16720-16725. PMID: 23012427, PMCID: PMC3478611, DOI: 10.1073/pnas.1208494109.
Response to critiques on ‘Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis’Bloch M, Hannestad J. Response to critiques on ‘Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis’. Molecular Psychiatry 2012, 17: 1163-1167. DOI: 10.1038/mp.2012.116.
Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive DisorderBloch MH, Wasylink S, Landeros-Weisenberger A, Panza KE, Billingslea E, Leckman JF, Krystal JH, Bhagwagar Z, Sanacora G, Pittenger C. Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder. Biological Psychiatry 2012, 72: 964-970. PMID: 22784486, PMCID: PMC3667652, DOI: 10.1016/j.biopsych.2012.05.028.
Commentaries on ‘Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders’Bloch MH, Gorman D, Abi‐Jaoude E. Commentaries on ‘Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders’. Evidence-Based Child Health A Cochrane Review Journal 2012, 7: 1231-1234. PMID: 25152702, PMCID: PMC4140657, DOI: 10.1002/ebch.1862.
Meta-analysis of Long-Chain Polyunsaturated Fatty Acid Supplementation of Formula and Infant CognitionQawasmi A, Landeros-Weisenberger A, Leckman JF, Bloch MH. Meta-analysis of Long-Chain Polyunsaturated Fatty Acid Supplementation of Formula and Infant Cognition. Pediatrics 2012, 129: 1141-1149. PMID: 22641753, PMCID: PMC3362904, DOI: 10.1542/peds.2011-2127.
Pharmacologic Treatment of Repetitive Behaviors in Autism Spectrum Disorders: Evidence of Publication BiasCarrasco M, Volkmar FR, Bloch MH. Pharmacologic Treatment of Repetitive Behaviors in Autism Spectrum Disorders: Evidence of Publication Bias. Pediatrics 2012, 129: e1301-e1310. PMID: 22529279, PMCID: PMC3340598, DOI: 10.1542/peds.2011-3285.
D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis.Bontempo A, Panza KE, Bloch MH. D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis. The Journal Of Clinical Psychiatry 2012, 73: 533-7. PMID: 22579153, PMCID: PMC3625928, DOI: 10.4088/jcp.11r07356.
Systematic Review of Proinflammatory Cytokines in Obsessive-Compulsive DisorderGray SM, Bloch MH. Systematic Review of Proinflammatory Cytokines in Obsessive-Compulsive Disorder. Current Psychiatry Reports 2012, 14: 220-228. PMID: 22477442, PMCID: PMC3625952, DOI: 10.1007/s11920-012-0272-0.
Family accommodation in obsessive–compulsive disorderLebowitz ER, Panza KE, Su J, Bloch MH. Family accommodation in obsessive–compulsive disorder. Expert Review Of Neurotherapeutics 2012, 12: 229-238. PMID: 22288678, PMCID: PMC4011018, DOI: 10.1586/ern.11.200.
Relationship of Dropout and Psychopathology in a High School Sample in MexicoChalita PJ, Palacios L, Cortes JF, Landeros-Weisenberger A, Panza KE, Bloch MH. Relationship of Dropout and Psychopathology in a High School Sample in Mexico. Frontiers In Psychiatry 2012, 3: 20. PMID: 22419912, PMCID: PMC3300101, DOI: 10.3389/fpsyt.2012.00020.
Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatmentPittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment. Pharmacology & Therapeutics 2011, 132: 314-332. PMID: 21963369, PMCID: PMC3205262, DOI: 10.1016/j.pharmthera.2011.09.006.
Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysisBloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Molecular Psychiatry 2011, 17: 1272-1282. PMID: 21931319, PMCID: PMC3625950, DOI: 10.1038/mp.2011.100.
Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-AnalysisBloch MH, Qawasmi A. Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-Analysis. Journal Of The American Academy Of Child & Adolescent Psychiatry 2011, 50: 991-1000. PMID: 21961774, PMCID: PMC3625948, DOI: 10.1016/j.jaac.2011.06.008.
Anxiety and Special Impulse Control DisordersThienemann M, Hinman K, Bloch M, Leckman J. Anxiety and Special Impulse Control Disorders. 2011, 91-127. DOI: 10.1142/9789814324823_0005.
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-AnalysisHannestad J, DellaGioia N, Bloch M. The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis. Neuropsychopharmacology 2011, 36: 2452-2459. PMID: 21796103, PMCID: PMC3194072, DOI: 10.1038/npp.2011.132.
Dimensional correlates of poor insight in obsessive–compulsive disorderJakubovski E, Pittenger C, Torres AR, Fontenelle LF, do Rosario MC, Ferrão YA, de Mathis MA, Miguel EC, Bloch MH. Dimensional correlates of poor insight in obsessive–compulsive disorder. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2011, 35: 1677-1681. PMID: 21640153, PMCID: PMC4048951, DOI: 10.1016/j.pnpbp.2011.05.012.
Tourette’s Syndrome and Tic-Related Disorders in ChildrenLombroso P, Bloch M, Leckman J. Tourette’s Syndrome and Tic-Related Disorders in Children. 2011, 1218-1229. DOI: 10.1093/med/9780199798261.003.0075.
Recent advances in Tourette syndromeBloch M, State M, Pittenger C. Recent advances in Tourette syndrome. Current Opinion In Neurology 2011, 24: 119-125. PMID: 21386676, PMCID: PMC4065550, DOI: 10.1097/wco.0b013e328344648c.
Pharmacological Treatment for Phobias and Anxiety DisordersBloch M, McGuire J. Pharmacological Treatment for Phobias and Anxiety Disorders. 2011, 339-354. DOI: 10.1007/978-1-4419-7784-7_23.
Poor fine‐motor and visuospatial skills predict persistence of pediatric‐onset obsessive‐compulsive disorder into adulthoodBloch MH, Sukhodolsky DG, Dombrowski PA, Panza KE, Craiglow BG, Landeros‐Weisenberger A, Leckman JF, Peterson BS, Schultz RT. Poor fine‐motor and visuospatial skills predict persistence of pediatric‐onset obsessive‐compulsive disorder into adulthood. Journal Of Child Psychology And Psychiatry 2011, 52: 974-983. PMID: 21244423, PMCID: PMC3625937, DOI: 10.1111/j.1469-7610.2010.02366.x.
Neurobiological Substrates of Tic DisordersLeckman J, Bloch M, Hampson M, King R. Neurobiological Substrates of Tic Disorders. 2010, 171-188. DOI: 10.1093/med/9780195398212.003.0012.
Time-Lag Bias in Trials of Pediatric Antidepressants: A Systematic Review and Meta-AnalysisReyes MM, Panza KE, Martin A, Bloch MH. Time-Lag Bias in Trials of Pediatric Antidepressants: A Systematic Review and Meta-Analysis. Journal Of The American Academy Of Child & Adolescent Psychiatry 2010, 50: 63-72. PMID: 21156271, PMCID: PMC3645909, DOI: 10.1016/j.jaac.2010.10.008.
Neurobiological Substrates of Tourette's DisorderLeckman JF, Bloch MH, Smith ME, Larabi D, Hampson M. Neurobiological Substrates of Tourette's Disorder. Journal Of Child And Adolescent Psychopharmacology 2010, 20: 237-247. PMID: 20807062, PMCID: PMC2958453, DOI: 10.1089/cap.2009.0118.
The Genetics of Obsessive-Compulsive Disorder.Bloch MH, Pittenger C. The Genetics of Obsessive-Compulsive Disorder. Current Psychiatry Research And Reviews 2010, 6: 91-103. PMID: 23970845, PMCID: PMC3747631, DOI: 10.2174/157340010791196439.
Predictors of early adulthood quality of life in children with obsessive–compulsive disorderPalermo SD, Bloch MH, Craiglow B, Landeros-Weisenberger A, Dombrowski PA, Panza K, Smith ME, Peterson BS, Leckman JF. Predictors of early adulthood quality of life in children with obsessive–compulsive disorder. Social Psychiatry And Psychiatric Epidemiology 2010, 46: 291-297. PMID: 20191262, PMCID: PMC3645906, DOI: 10.1007/s00127-010-0194-2.
Obsessive-Compulsive Anxiety Disorders in ChildhoodBloch M, Leckman J. Obsessive-Compulsive Anxiety Disorders in Childhood. 2010, 914-918. DOI: 10.1007/978-3-540-68706-1_124.
Cognitive Behavioral TherapyBloch M, Leckman J. Cognitive Behavioral Therapy. 2010, 313-314. DOI: 10.1007/978-3-540-68706-1_1429.
Number Needed to TreatBloch M, Leckman J. Number Needed to Treat. 2010, 907-907. DOI: 10.1007/978-3-540-68706-1_1430.
Habit Reversal TrainingBloch M. Habit Reversal Training. 2010, 563-563. DOI: 10.1007/978-3-540-68706-1_910.
Habit Reversal TherapyBloch M. Habit Reversal Therapy. 2010, 563-563. DOI: 10.1007/978-3-540-68706-1_911.
Effect SizeBloch M. Effect Size. 2010, 456-456. DOI: 10.1007/978-3-540-68706-1_912.
TrichotillomaniaBloch M. Trichotillomania. 2010, 1340-1343. DOI: 10.1007/978-3-540-68706-1_383.
Clinical course of Tourette syndromeBloch MH, Leckman JF. Clinical course of Tourette syndrome. Journal Of Psychosomatic Research 2009, 67: 497-501. PMID: 19913654, PMCID: PMC3974606, DOI: 10.1016/j.jpsychores.2009.09.002.
Predictors of Early Adult Outcomes in Pediatric-Onset Obsessive-Compulsive DisorderBloch MH, Craiglow BG, Landeros-Weisenberger A, Dombrowski PA, Panza KE, Peterson BS, Leckman JF. Predictors of Early Adult Outcomes in Pediatric-Onset Obsessive-Compulsive Disorder. Pediatrics 2009, 124: 1085-1093. PMID: 19786445, PMCID: PMC3974608, DOI: 10.1542/peds.2009-0015.
Trichotillomania Across the Life SpanBloch MH, Kratochvil C, Bloch M. Trichotillomania Across the Life Span. Journal Of The American Academy Of Child & Adolescent Psychiatry 2009, 48: 879-883. PMID: 19692854, DOI: 10.1097/chi.0b013e3181ae09f3.
Dimensional predictors of response to SRI pharmacotherapy in obsessive–compulsive disorderLanderos-Weisenberger A, Bloch MH, Kelmendi B, Wegner R, Nudel J, Dombrowski P, Pittenger C, Krystal JH, Goodman WK, Leckman JF, Coric V. Dimensional predictors of response to SRI pharmacotherapy in obsessive–compulsive disorder. Journal Of Affective Disorders 2009, 121: 175-179. PMID: 19577308, PMCID: PMC3974618, DOI: 10.1016/j.jad.2009.06.010.
Symptom dimensions and subtypes of obsessive-compulsive disorder: a developmental perspectiveLeckman JF, Bloch MH, King RA. Symptom dimensions and subtypes of obsessive-compulsive disorder: a developmental perspective. Dialogues In Clinical Neuroscience 2009, 11: 21-33. PMID: 19432385, PMCID: PMC3181902, DOI: 10.31887/dcns.2009.11.1/jfleckman.
A Developmental and Evolutionary Perspective on Obsessive-Compulsive Disorder: Whence and Whither Compulsive Hoarding?Leckman JF, Bloch MH. A Developmental and Evolutionary Perspective on Obsessive-Compulsive Disorder: Whence and Whither Compulsive Hoarding? American Journal Of Psychiatry 2008, 165: 1229-1233. PMID: 18829875, DOI: 10.1176/appi.ajp.2008.08060891.
Riluzole in the Treatment of Mood and Anxiety DisordersPittenger C, Coric V, Banasr M, Bloch M, Krystal JH, Sanacora G. Riluzole in the Treatment of Mood and Anxiety Disorders. CNS Drugs 2008, 22: 761-786. PMID: 18698875, DOI: 10.2165/00023210-200822090-00004.
Model Curriculum for Academic Child and Adolescent Psychiatry TrainingStubbe D, Martin A, Bloch M, Belitsky R, Carter D, Ebert M, Friedman A, Giese A, Kirwin P, Ross RG, Leckman JF. Model Curriculum for Academic Child and Adolescent Psychiatry Training. Academic Psychiatry 2008, 32: 366-376. PMID: 18945975, DOI: 10.1176/appi.ap.32.5.366.
Emerging treatments for Tourette’s disorderBloch MH. Emerging treatments for Tourette’s disorder. Current Psychiatry Reports 2008, 10: 323. PMID: 18627671, DOI: 10.1007/s11920-008-0052-z.
Tic DisordersLeckman J, Bloch M. Tic Disorders. 2008, 719-736. DOI: 10.1002/9781444300895.ch44.
Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive DisorderPittenger C, Kelmendi B, Wasylink S, Bloch MH, Coric V. Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder. Journal Of Clinical Psychopharmacology 2008, 28: 363-367. PMID: 18480706, DOI: 10.1097/jcp.0b013e3181727548.
Response to Chamberlain et al. Re: Systematic Review: Pharmacological and Behavioral Treatments for TrichotillomaniaBloch M, Landeros-Weisenberger A, Dombrowski P, Nudel J, Pittenger C, Leckman J, Kelmendi B, Wegner R, Coric V. Response to Chamberlain et al. Re: Systematic Review: Pharmacological and Behavioral Treatments for Trichotillomania. Biological Psychiatry 2008, 63: e34-e35. DOI: 10.1016/j.biopsych.2008.01.022.
Association of the serotonin transporter polymorphism and obsessive‐compulsive disorder: Systematic reviewBloch MH, Landeros‐Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V, Pittenger C, Leckman JF. Association of the serotonin transporter polymorphism and obsessive‐compulsive disorder: Systematic review. American Journal Of Medical Genetics Part B Neuropsychiatric Genetics 2008, 147B: 850-858. PMID: 18186076, DOI: 10.1002/ajmg.b.30699.
Systematic Review: Pharmacological and Behavioral Treatment for TrichotillomaniaBloch MH, Landeros-Weisenberger A, Dombrowski P, Kelmendi B, Wegner R, Nudel J, Pittenger C, Leckman JF, Coric V. Systematic Review: Pharmacological and Behavioral Treatment for Trichotillomania. Biological Psychiatry 2007, 62: 839-846. PMID: 17727824, DOI: 10.1016/j.biopsych.2007.05.019.
Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania.Coric V, Kelmendi B, Pittenger C, Wasylink S, Bloch MH, Green J. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania. The Journal Of Clinical Psychiatry 2007, 68: 170-1. PMID: 17284151, DOI: 10.4088/jcp.v68n0123f.
25 Tourette's SyndromeLeckman J, Bloch M. 25 Tourette's Syndrome. 2007, 385-408. DOI: 10.1016/b978-012369509-3.50027-5.
From Too Little Too Late to Early and Often: Child Psychiatry Education During Medical School (and Before and After)Martin A, Bloch M, Pruett K, Stubbe D, Belitsky R, Ebert M, Leckman JF. From Too Little Too Late to Early and Often: Child Psychiatry Education During Medical School (and Before and After). Child And Adolescent Psychiatric Clinics Of North America 2007, 16: 17-43. PMID: 17141116, DOI: 10.1016/j.chc.2006.07.005.
Tourette Syndrome: The Self Under SiegeLeckman JF, Bloch MH, Scahill L, King RA. Tourette Syndrome: The Self Under Siege. Journal Of Child Neurology 2006, 21: 642-649. PMID: 16970864, DOI: 10.1177/08830738060210081001.
Erratum: A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorderBloch M, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken M, Leckman J. Erratum: A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry 2006, 11: 795-795. DOI: 10.1038/sj.mp.4001859.
Fine‐motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndromeBloch MH, Sukhodolsky DG, Leckman JF, Schultz RT. Fine‐motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome. Journal Of Child Psychology And Psychiatry 2006, 47: 551-559. PMID: 16712631, DOI: 10.1111/j.1469-7610.2005.01561.x.
Systematic Review: Antipsychotic Augmentation for Treatment-Resistant Obsessive-Compulsive DisorderBloch MH, Landeros-Weisenberger A, Kelmendi BK, Coric V, Bracken MB, Leckman JF. Systematic Review: Antipsychotic Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder. Molecular Psychiatry 2006; 11: 622-632.
Adulthood Outcome of Tic and Obsessive-Compulsive Symptom Severity in Children With Tourette SyndromeBloch MH, Peterson BS, Scahill L, Otka J, Katsovich L, Zhang H, Leckman JF. Adulthood Outcome of Tic and Obsessive-Compulsive Symptom Severity in Children With Tourette Syndrome. JAMA Pediatrics 2006, 160: 65-69. PMID: 16389213, PMCID: PMC2291298, DOI: 10.1001/archpedi.160.1.65.
Phenomenology of tics and natural history of tic disorders.Leckman JF, Bloch MH, King RA, Scahill L. Phenomenology of tics and natural history of tic disorders. Advances In Neurology 2006, 99: 1-16. PMID: 16536348.
Clinical treatment of obsessive compulsive disorder.Pittenger C, Kelmendi B, Bloch M, Krystal JH, Coric V. Clinical treatment of obsessive compulsive disorder. Innov Clin Neurosci 2005, 2: 34-43. PMID: 21120095, PMCID: PMC2993523.
Caudate volumes in childhood predict symptom severity in adults with Tourette syndromeBloch MH, Leckman JF, Zhu H, Peterson BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005, 65: 1253-1258. PMID: 16247053, PMCID: PMC2367161, DOI: 10.1212/01.wnl.0000180957.98702.69.
Paraneoplastic Limbic Encephalitis: Ovarian Cancer Presenting as an Amnesic SyndromeBloch MH, Hwang WC, Baehring JM, Chambers SK. Paraneoplastic Limbic Encephalitis: Ovarian Cancer Presenting as an Amnesic Syndrome. Obstetrics And Gynecology 2004, 104: 1174-1177. PMID: 15516442, DOI: 10.1097/01.aog.0000128110.31784.c8.

Clinical Trials

Conditions	Study Title
Mental Health & Behavioral Research	Ketamine for Adolescent Suicidality
Diseases of the Nervous System; Mental Health & Behavioral Research	Teen Brain and Behavior Study
Child Development & Autism; Diseases of the Nervous System; Genetics - Adult; Genetics - Pediatric; Mental Health & Behavioral Research	Genetic and molecular studies of developmental neuropsychiatric disorders
Diseases of the Nervous System; Mental Health & Behavioral Research	Examination of Glutamate and mGluR5 in Psychiatric Disorders
Diseases of the Nervous System; Genetics - Adult; Genetics - Pediatric; Mental Health & Behavioral Research	Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART)
Mental Health & Behavioral Research	Imaging SV2A in mood disorders
Diseases of the Nervous System; Mental Health & Behavioral Research	Biomarkers of Clinical Subtype and Treatment Response in Obsessive-Compulsive Disorder
Diseases of the Nervous System; Mental Health & Behavioral Research	Neurofeedback for Obsessive-Compulsive Disorder
Diseases of the Nervous System	PET and MRI in OCD and/or Tic disorders
Child Development & Autism; Children's Health; Mental Health & Behavioral Research	Neurofeedback for Tourette Syndrome

Edit Profile

Michael Bloch, MD, MS

Contact Information

Office Location

Related Links

Patient Care

Research & Publications

Biography

News